Skip to main content
Article
Optimizing use of SGLT2 inhibitors and other evidence-based therapies to improve outcomes in patients with type 2 diabetes and chronic kidney disease: An opportunity for pharmacists.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
  • Joshua J Neumiller
  • Jay H Shubrook
  • Tom Manley
  • Radica Alicic, Providence Medical Research Center, Providence Health Care, Spokane, WA
  • Katherine Tuttle, Providence Medical Research Center, Providence Health Care, Spokane, WA
Document Type
Article
Publication Date
1-1-2022
Keywords
  • washington,
  • spokane,
  • Diabetes Mellitus, Type 2,
  • Humans,
  • Pharmacists,
  • Renal Insufficiency, Chronic,
  • Sodium-Glucose Transporter 2 Inhibitors
Clinical Institute
Kidney & Diabetes
Department
Endocrinology
Department
Nephrology
Citation Information
Joshua J Neumiller, Jay H Shubrook, Tom Manley, Radica Alicic, et al.. "Optimizing use of SGLT2 inhibitors and other evidence-based therapies to improve outcomes in patients with type 2 diabetes and chronic kidney disease: An opportunity for pharmacists." American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists (2022)
Available at: http://works.bepress.com/katherine-tuttle/346/